Abstract:
In the context of the COVID-19 pandemic, studying the peculiarities of organ and system damage in patients is of utmost importance. Currently, COVID-19 is considered a systemic disease that disrupts the immune system and primarily affects the lungs, as well as the heart, kidneys, and intestines. Severe cases are characterized by hyperimmune inflammation, renin-angiotensin-aldosterone system imbalance, endothelial dysfunction, and specific vasculopathies such as thrombotic microangiopathy and intravascular coagulopathy. This condition, referred to by some experts as a thromboinflammatory process or COVID-19- associated coagulopathy, represents a critical area of research
